HeartBeam (BEAT) announced the appointment of Bryan Humbarger as chief commercial officer, effective January 22. In this newly created role, Humbarger will lead commercial strategy and execution across the company’s initiatives. Most recently, he served as chief commercial officer at the venture-backed surgical guidance company Proprio.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAT:
- FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup
- HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference
- HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation
- 3 Penny Stocks to Watch Now, 12/18/25
- 3 Penny Stocks to Watch Now, 12/16/25